Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 03/12/2024 +03
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.33M 1.25M 1.14M 2.15M 149M 2.19M 14.77M 5.76M 74.74M 5.85M 5.72M 247M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -27.72M -25.87M -23.73M -44.6M -3.1B -45.48M -307M -120M -1.55B -122M -119M -5.14B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/20/24 A | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 A | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 A | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.71% | 1.56M | |
| -0.14% | +4.09% | +3.28% | +24.62% | 51.22B | |
| -1.36% | +4.82% | +485.55% | +614.84% | 45.38B | |
| -2.04% | +3.69% | +19.34% | +91.23% | 41.97B | |
| +2.72% | +6.02% | +33.33% | +19.66% | 42.15B | |
| 0.00% | -3.91% | +18.49% | +47.98% | 31.95B | |
| -1.85% | +3.48% | - | - | 16.73B | |
| +0.72% | +5.27% | +31.55% | +145.37% | 17.1B | |
| -0.74% | +2.61% | +6.29% | +34.45% | 14.76B | |
| +0.50% | +3.62% | +82.64% | +46.53% | 13.91B | |
| Average | -2.63% | +0.33% | +75.61% | +103.66% | 27.52B | |
| Weighted average by Cap. | -0.23% | +3.18% | +103.67% | +150.89% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.28M 1.19M 1.09M 2.05M 143M 2.09M 14.12M 5.5M 71.45M 5.59M 5.47M 237M | 785K 672K 627K 575K 1.08M 75.11M 1.1M 7.44M 2.9M 37.64M 2.95M 2.88M 125M |
| Net income | -44.17M -37.82M -35.29M -32.38M -60.84M -4.23B -62.04M -419M -163M -2.12B -166M -162M -7.01B | -39.48M -33.8M -31.54M -28.94M -54.38M -3.78B -55.45M -374M -146M -1.89B -148M -145M -6.27B |
| Net Debt | -63.64M -54.49M -50.84M -46.65M -87.65M -6.09B -89.38M -603M -235M -3.05B -239M -234M -10.1B | -33.94M -29.06M -27.11M -24.88M -46.74M -3.25B -47.66M -322M -125M -1.63B -127M -125M -5.39B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
